Pfizer (PFE), Merck KGaA Announce Receipt of FDA Fast-Track Designation for Avelumab
Tweet Send to a Friend
Merck KGaA, Darmstadt, Germany, and Pfizer (NYSE: PFE) announced that the US Food and Drug Administration (FDA) has granted avelumab ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
